
GENITOURINARY CANCERS
Latest News
Advertisement
Latest Videos

Advertisement
More News

Howard I. Scher, MD, from the Memorial Sloan-Kettering Cancer Center, discusses an updated analysis of the COU-AA-302 trial.

William K. Oh, MD, Chief of the Division of Hematology and Medical Oncology, the Tisch Cancer Institute at Mount Sinai Medical Center, discusses sequencing treatment in patients with metastatic castration resistant prostate cancer.
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
ASCO 2026 Breast Cancer Trials Affirm De-Escalation, Earlier Switching
2
Arlo-Cel Shows Promise in Early-Line Relapsed Multiple Myeloma
3
Puxitatug Samrotecan Hits 60% Response Rate in Platinum- and IO-Pretreated Endometrial Cancer
4
When Consensus Outpaces Capacity in Second-Line Melanoma
5


















































